Michael Wald
Papers
1
Total Citations
59
H-Index
1
About
Michael Wald is a leading researcher in the rehabilitation of chronic spinal cord injury (SCI), with a particular focus on musculoskeletal deterioration and bone health. His work bridges endocrinology and physical rehabilitation, exploring how anabolic agents and mechanical loading can counteract severe bone loss in nonambulatory patients. In his landmark pilot study, "Effect of Parathyroid Hormone Combined With Gait Training on Bone Density and Bone Architecture in People With Chronic Spinal Cord Injury" (2013, 59 citations), Wald demonstrated that combining teriparatide (a parathyroid hormone analog) with robotic-assisted gait training could stimulate bone formation in individuals with chronic SCI—a population typically resistant to conventional therapies. This pioneering work provided the first evidence that dual anabolic stimuli could improve bone density and microarchitecture in paralyzed limbs, opening new avenues for preventing fractures and enhancing long-term health outcomes. Wald’s research is distinguished by its translational approach, directly addressing a critical, underserved clinical need. His contributions have shaped rehabilitation protocols and inspired further investigation into pharmacological-exercise synergies for neurological populations.
Research Focus
Key Achievements
Top Papers
- 1